<DOC>
	<DOCNO>NCT02253797</DOCNO>
	<brief_summary>Study evaluate pharmacokinetics Tipranavir metabolites include excretion mass balance parent compound radioactivity steady-state ; isolate , identify quantify major metabolite tipranavir plasma , urine feces</brief_summary>
	<brief_title>Pharmacokinetics Tipranavir/Ritonavir Its Metabolites Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<criteria>1 . Healthy HIVnegative male subject determine result screen . Healthiness determine medical history , laboratory test 12lead ECG 2 . Signed write informed consent accordance Good Clinical Practice ( GCP ) 3 . Age &gt; 18 &lt; =60 year 4 . Subjects within 20 % normal height : weight range define Metropolitan Life Insurance Company Tables 5 . Ability swallow numerous large capsule 6 . Willingness abstain smoking , ingest methylxanthine contain drink food ( coffee , tea , cola , chocolate , etc . ) , ingest alcohol , St. John 's Wort , milk thistle , garlic supplement , Seville oranges , grapefruit grapefruit juice duration study 1 . Any finding medical examination ( include blood pressure , pulse rate , ECG ) deviate normal clinical relevance 2 . History clinically significant disease include metabolic , endocrinologic , immunological , hepatic , renal , gastrointestinal , respiratory , cardiovascular , psychiatric neurological 3 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator and/or sponsor 4 . Subjects history drug abuse alcoholism 5 . Chronic relevant acute ( within 2 week screen ) infection 6 . Subjects take prescription medication , overthecounter drug , herbal preparation within 2 week start trial 7 . Participation another trial investigational drug ( 30 day prior screen ) 8 . Blood donation &gt; 400 mL ( within 1 month prior treatment administration trial ) 9 . Any laboratory value represent Division DAIDS ( DAIDS ) toxicity Grade &gt; 1 10 . Positive urine drug screen , positive HIV antibody , positive Hepatitis C Ribonucleic acid ( RNA ) , positive Hepatitis B surface antigen 11 . History familial bleeding disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>